|
The Immunohistochemistry Antibody Company
|
|
|
Skin Cancer Screen 35 Tissue Microarray - LS-SSKCA35This tissue microarray is available for use in LSBio Immunohistochemistry Studies only. |
| Catalog ID: | LS-SSKCA35 |
| Product Name: | Skin Cancer Screen 35 |
| Description: | (15 cases of squamous cell carcinoma, 3 metastatic adenocarcinoma, 10 syringocarcinoma, 1 sebaceous adenocarcinoma, 2 adenoid cystic carcinoma, 14 basal cell carcinoma, 15 each of sarcoma and malignant melanoma, 3 normal skin) |
| Format: | FFPE |
| Category: | Human Tumor |
| QA/QC: | H&E reviewed; IHC validated with a positive control antibody |
| Storage: | Short term RT; Long term 4ºC |
| Clinical History: | No |
| Tissue Marker: | No |
| Stage/Grade: | Yes |
| Core Diameter: | 1.5 mm |
| Core Thickness: | 5 µm |
| Cases: | 78 |
| Cores: | 79 |
| Slides Per Set: | 1 |
| LABEL |
|
| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type | Tumor Grade |
|---|---|---|---|---|---|---|---|---|
| 1 | A1 | Human | F | 84 y | Skin, Face (Skn) | Squamous cell carcinoma | Malignant | 1 |
| 1 | A2 | Human | F | 80 y | Skin, Face (Skn) | Squamous cell carcinoma | Malignant | 1 |
| 1 | A3 | Human | F | 85 y | Skin, Face (Skn) | Squamous cell carcinoma | Malignant | 1 |
| 1 | A4 | Human | M | 37 y | Skin, Head (Skn) | Squamous cell carcinoma | Malignant | 1 |
| 1 | A5 | Human | F | 85 y | Skin, Face (Skn) | Squamous cell carcinoma | Malignant | 1 |
| 1 | A6 | Human | F | 52 y | Skin, Head (Skn) | Squamous cell carcinoma | Malignant | 2 |
| 1 | A7 | Human | F | 62 y | Skin, Jaw (Skn) | Squamous cell carcinoma | Malignant | 2 |
| 1 | A8 | Human | F | 66 y | Skin, Nose (Skn) | Squamous cell carcinoma | Malignant | 3 |
| 1 | A9 | Human | M | 65 y | Skin, Head (Skn) | Squamous cell carcinoma | Malignant | 1 |
| 1 | B1 | Human | M | 73 y | Skin, Abdomen (Skn) | Squamous cell carcinoma | Malignant | 1 |
| 1 | B2 | Human | F | 52 y | Skin, Limb (Skn) | Squamous cell carcinoma | Malignant | 1 |
| 1 | B3 | Human | M | 68 y | Skin (Skn) | Squamous cell carcinoma | Malignant | 3 |
| 1 | B4 | Human | M | 51 y | Skin, Leg (Skn) | Squamous cell carcinoma | Malignant | 2 |
| 1 | B5 | Human | M | 34 y | Skin (Skn) | Squamous cell carcinoma | Malignant | 1 |
| 1 | B6 | Human | M | 58 y | Skin, Back (Skn) | Squamous cell carcinoma | Malignant | 1 |
| 1 | B7 | Human | M | 82 y | Skin, Abdomen (Skn) | Metastasis from abdominal wall adenocarcinoma | Metastatic | 2 |
| 1 | B8 | Human | M | 45 y | Skin, Head (Skn) | Clear cell sweat gland carcinoma | Malignant | |
| 1 | B9 | Human | M | 64 y | Skin (Skn) | Sweat gland carcinoma | Malignant | 3 |
| 1 | C1 | Human | M | 88 y | Skin, Face (Skn) | Sweat gland carcinoma | Malignant | 3 |
| 1 | C2 | Human | M | 50 y | Skin, Abdomen (Skn) | Metastasis from abdominal wall adenocarcinoma | Metastatic | 3 |
| 1 | C3 | Human | M | 68 y | Skin, Neck (Skn) | Metastatic adenocarcinoma | Metastatic | 2 |
| 1 | C4 | Human | M | 52 y | Skin, Head (Skn) | Clear cell sweat gland carcinoma | Malignant | |
| 1 | C5 | Human | M | 41 y | Skin, Abdomen (Skn) | Sweat gland carcinoma | Malignant | 3 |
| 1 | C6 | Human | F | 60 y | Skin (Skn) | Sweat gland carcinoma | Malignant | 3 |
| 1 | C7 | Human | M | 67 y | Skin, Head (Skn) | Adenocarcinoma, Sebaceous | Malignant | |
| 1 | C8 | Human | F | 54 y | Skin, Head (Skn) | Adenoid cystic carcinoma | Malignant | |
| 1 | C9 | Human | M | 53 y | Skin, Perineum (Skn) | Sweat gland carcinoma | Malignant | 3 |
| 1 | D1 | Human | M | 68 y | Skin, Perineum (Skn) | Clear cell sweat gland carcinoma | Malignant | |
| 1 | D2 | Human | F | 50 y | Skin, Abdomen (Skn) | Sweat gland carcinoma | Malignant | 3 |
| 1 | D3 | Human | F | 63 y | Skin (Skn) | Adenoid cystic carcinoma | Malignant | |
| 1 | D4 | Human | M | 73 y | Skin, Face (Skn) | Basal cell carcinoma | Malignant | |
| 1 | D5 | Human | M | 38 y | Skin, Face (Skn) | Basal cell carcinoma | Malignant | |
| 1 | D6 | Human | F | 73 y | Skin, Eyelid (Skn) | Basal cell carcinoma | Malignant | |
| 1 | D7 | Human | M | 87 y | Skin, Head (Skn) | Basal cell carcinoma | Malignant | |
| 1 | D8 | Human | F | 75 y | Skin, Eyelid (Skn) | Sweat gland carcinoma | Malignant | 3 |
| 1 | D9 | Human | F | 76 y | Skin, Face (Skn) | Basal cell carcinoma | Malignant | |
| 1 | E1 | Human | F | 82 y | Skin, Leg (Skn) | Basal cell carcinoma | Malignant | |
| 1 | E2 | Human | M | 62 y | Skin, Head (Skn) | Basal cell carcinoma | Malignant | |
| 1 | E3 | Human | F | 54 y | Skin, Eyelid (Skn) | Basal cell carcinoma | Malignant | |
| 1 | E4 | Human | M | 41 y | Skin, Eyelid (Skn) | Basal cell carcinoma | Malignant | |
| 1 | E5 | Human | M | 44 y | Skin, Face (Skn) | Basal cell carcinoma | Malignant | |
| 1 | E6 | Human | F | 42 y | Skin, Head (Skn) | Basal cell carcinoma | Malignant | |
| 1 | E7 | Human | F | 70 y | Skin, Nose (Skn) | Basal cell carcinoma | Malignant | |
| 1 | E8 | Human | M | 55 y | Skin, Head (Skn) | Basal cell carcinoma with necrosis | Malignant | |
| 1 | E9 | Human | F | 85 y | Skin, Face (Skn) | Basal cell carcinoma | Malignant | |
| 1 | F1 | Human | M | 36 y | Skin, Abdomen (Skn) | Dermatofibrosarcoma protuberans | Malignant | |
| 1 | F2 | Human | M | 31 y | Skin, Abdomen (Skn) | Dermatofibrosarcoma protuberans | Malignant | |
| 1 | F3 | Human | M | 72 y | Skin, Chest (Skn) | Fibrosarcoma | Malignant | |
| 1 | F4 | Human | M | 25 y | Skin, Leg (Skn) | Dermatofibrosarcoma protuberans | Malignant | |
| 1 | F5 | Human | F | 39 y | Skin, Waist (Skn) | Dermatofibrosarcoma protuberans | Malignant | |
| 1 | F6 | Human | M | 54 y | Skin, Ear (Skn) | Malignant schwannoma | Malignant | |
| 1 | F7 | Human | M | 73 y | Skin, Shoulder (Skn) | Dermatofibrosarcoma protuberans | Malignant | |
| 1 | F8 | Human | M | 44 y | Skin, Back (Skn) | Malignant schwannoma | Malignant | |
| 1 | F9 | Human | F | 50 y | Skin, Back (Skn) | Dermatofibrosarcoma protuberans | Malignant | |
| 1 | G1 | Human | M | 72 y | Skin, Chest (Skn) | Sarcoma, Pleomorphic | Malignant | |
| 1 | G2 | Human | M | 32 y | Skin, Chest (Skn) | Dermatofibrosarcoma protuberans | Malignant | |
| 1 | G3 | Human | M | 15 y | Skin, Waist (Skn) | Dermatofibrosarcoma protuberans | Malignant | |
| 1 | G4 | Human | M | 55 y | Skin, Back (Skn) | Leiomyosarcoma | Malignant | |
| 1 | G5 | Human | M | 40 y | Skin, Leg (Skn) | Dermatofibrosarcoma protuberans | Malignant | |
| 1 | G6 | Human | F | 54 y | Skin, Back (Skn) | Malignant schwannoma | Malignant | |
| 1 | G7 | Human | F | 47 y | Skin, Perineum (Skn) | Malignant melanoma | Malignant | |
| 1 | G8 | Human | M | 79 y | Skin, Foot (Skn) | Malignant melanoma | Malignant | |
| 1 | G9 | Human | M | 76 y | Skin, Leg (Skn) | Malignant melanoma | Malignant | |
| 1 | H1 | Human | M | 25 y | Skin, Medial malleolus (Skn) | Malignant melanoma | Malignant | |
| 1 | H2 | Human | M | 70 y | Skin, Foot (Skn) | Malignant melanoma | Malignant | |
| 1 | H3 | Human | M | 49 y | Skin, Shoulder (Skn) | Malignant melanoma | Malignant | |
| 1 | H4 | Human | M | 36 y | Skin, Back (Skn) | Malignant melanoma | Malignant | |
| 1 | H5 | Human | M | 71 y | Skin, Leg (Skn) | Malignant melanoma | Malignant | |
| 1 | H6 | Human | M | 65 y | Skin, Foot (Skn) | Malignant melanoma | Malignant | |
| 1 | H7 | Human | M | 66 y | Skin, Leg (Skn) | Malignant melanoma | Malignant | |
| 1 | H8 | Human | F | 66 y | Skin, Chest (Skn) | Malignant melanoma | Malignant | |
| 1 | H9 | Human | M | 82 y | Skin, Face (Skn) | Malignant melanoma | Malignant | |
| 1 | I1 | Human | M | 61 y | Skin, Foot (Skn) | Malignant melanoma | Malignant | |
| 1 | I2 | Human | F | 47 y | Skin, Arm (Skn) | Malignant melanoma | Malignant | |
| 1 | I3 | Human | M | 57 y | Skin, Shoulder (Skn) | Malignant melanoma | Malignant | |
| 1 | I4 | Human | F | 75 y | Skin, Hand (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | I5 | Human | M | 63 y | Skin, Chest (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | I6 | Human | F | 49 y | Skin (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | I10 | Unknown | U | Unknown (Unk) | Unknown | Unknown |